Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative delirium after lumbar spine surgery in elderly patients
ChiCTR2500108377Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) and post-operative cognitive decline (POCD) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Occurrence of postoperative delirium. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2500108377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108377.